
Macromoltek
Computational antibody design
Austin, US
AI-powered Drug DiscoveryDeep LearningTherapeutics
Macromoltek: Revolutionizing antibody design.
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Meet the team2
The people behind Macromoltek
Monica Berrondo
Founder/CEO
Susana Kaufmann
Founder/CTO